Current status date:
2021-08-10
DIN:
02237537
Electronic product monograph is not available
Company:
APOTEX INC
150 Signet Drive
Toronto
Ontario
Canada
M9L 1T9
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS):
See footnote 3
28:16.08.92
Anatomical Therapeutic Chemical (ATC):
See footnote 4
N05AH01 LOXAPINE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
LOXAPINE (LOXAPINE SUCCINATE)
|
50 MG
|